Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma
2020 · BMC Cancer · 48 citations
https://doi.org/10.1186/s12885-020-07536-3
B
Bo Zhao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
611
Citations
13
h-index
15
i10-index
Bo Zhao is an academic researcher from Tongji University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Sarcoma Diagnosis and Treatment & Animal Disease Management and Epidemiology. The author has an h-index of 13, co-authored 40 publications.
ORCID: 0000-0003-3937-3376Papers by this author
worksLoss of neurodevelopmental-associated miR-592 impairs neurogenesis and causes social interaction deficits
2022 · Cell Death and Disease · 8 citations
https://doi.org/10.1038/s41419-022-04721-z
Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas
2021 · Figshare · 1 citations
https://doi.org/10.6084/m9.figshare.14035377
Inflammation as a mediator of air pollution's role in Alzheimer's disease and related dementias
2025 · Journal of Alzheimer s Disease · 0 citations
https://doi.org/10.1177/13872877251408422
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat